Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Norovent AS
AS
Active
Org 955521668
Jovegen 73A, 5514
Haugesund
Ventilasjonsarbeid
·
NACE 43223
Est. 1990 · 36 years old
8 employees
norovent.no
Monitor
Share
Norway
/
Companies
/
Ventilasjonsarbeid
/
Norovent AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
17M
13M
9M
4M
0M
2021: 12M
12M
2021
2022: 13M (+8% vs 2021)
13M
+8%
2022
2023: 13M (0% vs 2022)
13M
0%
2023
2024: 13M (0% vs 2023)
13M
0%
2024
2025: 14M (+8% vs 2024)
14M
+8%
2025
EBITDA
NOK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
13 903
13 429
12 588
12 736
11 611
Staff expenses
−5 253
−4 767
−4 444
−4 845
−4 442
EBITDA
1 031
941
1 222
1 096
1 297
Depreciation & amort.
−389
−360
−340
−268
−228
EBIT
642
581
881
828
1 070
Net financials
−3
−14
−3
−14
1
Profit before tax
639
568
878
813
1 071
Tax
140
125
193
179
236
Net profit
498
443
685
634
835
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
5 320
4 701
4 852
4 396
3 839
Equity
2 381
2 354
2 075
1 562
1 270
Long-term debt
0
445
891
189
66
Short-term debt
2 660
1 902
1 886
2 645
2 503
Total debt
2 939
2 348
2 777
2 834
2 570
Financial ratios
5-year trend
EBITDA margin
7,4 %
This company
15,8 %
Market median
This company
Market median
53% below market
2021
2025
Equity ratio
44,8 %
This company
38,2 %
Market median
This company
Market median
17% above market
2021
2025
Return on equity
20,9 %
This company
18,4 %
Market median
This company
Market median
14% above market
2021
2025
Net profit margin
3,6 %
This company
8,1 %
Market median
This company
Market median
56% below market
2021
2025
Asset turnover
2,61×
This company
1,12×
Market median
This company
Market median
133% above market
2021
2025
Debt / equity
1,23×
This company
0,62×
Market median
This company
Market median
98% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Norovent AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
